RETINAL VASCULITIS
Clinical trials for RETINAL VASCULITIS explained in plain language.
Never miss a new study
Get alerted when new RETINAL VASCULITIS trials appear
Sign up with your email to follow new studies for RETINAL VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive eye study reveals rare side effect of common injection
Knowledge-focused CompletedThis study examined over 550,000 patients to find out how often retinal vasculitis (inflammation of blood vessels in the eye) occurs after treatment with aflibercept (Eylea®). Researchers reviewed medical records to confirm cases and identify types of vasculitis. The goal was to …
Matched conditions: RETINAL VASCULITIS
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 07:58 UTC
-
Massive study reveals rare eye inflammation risk from common injection
Knowledge-focused CompletedThis study looked at medical records of about 290,000 people in the US who received aflibercept (Eylea) eye injections to treat various retinal diseases. The goal was to find out how often retinal vasculitis, a type of eye inflammation, occurred after the injections. Researchers …
Matched conditions: RETINAL VASCULITIS
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 07:27 UTC